08 November 2023 |
| 08:50-09:00 | | CME Day: Welcome and Introduction Chair(s): Dinesh Giri, CME Officer (Bristol, UK) Alex B Suite
|
| 09:00-10:00 | | CME Symposium 1 Chair(s): Dinesh Giri (Bristol, UK) & Julie Park (Liverpool, UK) Alex B Suite
|
| 09:00 | CME1.1 | An approach to XY DSD |
| 09:30 | CME1.2 | DSD: Difficult conversations |
| 10:00-10:30 | | CME Case Presentations 1 Chair(s): Dinesh Giri (Bristol, UK) & Julie Park (Liverpool, UK) Alex B Suite
|
| 10:00 | OC1.1 | 45,X/46,XY DSD with gender dysphoria: the conundrum around pubertal induction |
| 10:10 | OC1.2 | Swabbing for Staphylococcus in skin reactions to diabetic devices: not a rash decision |
| 10:20 | OC1.3 | Hyperpigmentation related to diabetes technology adhesives: an unusual presentation of Addison’s disease in a child with type 1 diabetes mellitus |
| 10:30-11:00 | | Tea & Coffee Trafford Suite
|
| 11:00-12:00 | | CME Symposium 2 Chair(s): Dinesh Giri (Bristol, UK) & Phil Murray (Manchester, UK) Alex B Suite
|
| 11:00 | CME2.1 | Arginine Vasopressin Deficiency and Postoperative management of water and electrolytes |
| 11:30 | CME2.2 | Osteoporosis in Children and Adolescents-Approach and management |
| 12:00-12:30 | | CME Case Presentations 2 Chair(s): Dinesh Giri (Bristol, UK) & Phil Murray (Manchester, UK) Alex B Suite
|
| 12:00 | OC2.1 | Lessons learned from a case of fungal candida thyroiditis: a rare but serious condition |
| 12:10 | OC2.2 | Hypopituitarism – a rare manifestation in Joubert syndrome: About 4 cases |
| 12:20 | OC2.3 | Conquering the Storm: Surgical Intervention Rescues an Adolescent girl with Severe Thyrotoxicosis Refractory to Medical Management |
| 12:30-12:40 | | CSAC Trainee Representative Update Chair(s): Katherine Hawton (Bristol, UK), Salma Ali (Glasgow, UK) & Nicola Heddy (London, UK) Alex B Suite
|
| 12:40-13:30 | | Lunch & Exhibition Trafford Suite
|
| 13:30-14:30 | | CME Symposium 3 Chair(s): Dinesh Giri (Bristol, UK) & Bindu Avatapalle (Cardiff, UK) Alex B Suite
|
| 13:30 | CME3.1 | An approach towards the diagnosis and management of monogenic obesity |
| 14:00 | CME3.2 | Monogenic Diabetes in Children and Adolescents-Approach and management |
| 14:30-15:00 | | CME Case Presentations 3 Chair(s): Dinesh Giri (Bristol, UK) & Bindu Avatapalle (Cardiff, UK) Alex B Suite
|
| 14:30 | OC3.1 | The first description of an MC4R variant in a patient with Kallmann syndrome and obesity |
| 14:40 | OC3.2 | A novel maternally inherited GNAS variant in a family with hyperphagia and obesity |
| 14:50 | OC3.3 | A complex case of Pituitary Gigantism: Overcoming Challenges in Diagnosis and Treatment |
| 15:00-15:30 | | Tea & Coffee Trafford Suite
|
| 15:30-16:00 | | CME Symposium 4 Chair(s): Dinesh Giri (Bristol, UK) & Salma Ali (Glasgow, UK) Alex B Suite
|
| 15:30 | CME4.1 | Interpretation of Urinary steroid profiles in Paediatric Endocrinology |
| 16:00-16:30 | | CME Case Presentations 4 Chair(s): Dinesh Giri (Bristol, UK) & Salma Ali (Glasgow, UK) Alex B Suite
|
| 16:00 | OC4.1 | Cortisone reductase deficiency: a rare cause of hyperandrogenaemia and premature adrenarche. |
| 16:10 | OC4.2 | A deletion at 20p11.21 region involving FOXA2 causing Congenital Hyperinsulinism and extra pancreatic features |
| 16:20 | OC4.3 | Primary Adrenal Insufficiency with muco-candidiasis- A Rare Cause of Familial Glucocorticoid Deficiency due to Thioredoxin reductase deficiency |
| 16:30-16:45 | | CME Officer's Update & Conclusion Chair(s): Dinesh Giri, CME Officer (Bristol, UK) Alex B Suite
|
| 17:00-17:50 | | Industry Sponsored Satellite Symposium Please refer to the Industry Programme for full details Alex B Suite
|
| 17:00-18:00 | | Industry Sponsored Satellite Symposium Please refer to the Industry Programme for full details Alex A Suite
|
| 18:00-19:00 | | Welcome Reception Trafford Suite
|
09 November 2023 |
| 09:00-09:10 | | Welcome and Introduction Chair(s): Tabitha Randell - BSPED President (Nottingham, UK), Senthil Senniappan - POC Chair (Liverpool, UK) & Mars Skae - Local Convenor (Manchester, UK) Alex B Suite
|
| 09:10-10:40 | | Endocrine Oral Communications 1 Chair(s): Leena Patel (Manchester, UK) & Liz Crowne (Bristol, UK) Alex B Suite
|
| 09:10 | OC5.1 | Endocrine Outcomes in Bardet-Biedl Syndrome from a Large Single-Centre Paediatric Multidisciplinary Clinic |
| 09:20 | OC5.2 | Gonadotropin treatment for the induction or completion of puberty for males with hypogonadotropic hypogonadism; Two Centre Experience |
| 09:30 | OC5.3 | Origins of the lower vagina and the role of androgens from 20 years’ experience with genitoplasty for 46XX classical congenital adrenal hyperplasia (CAH) |
| 09:40 | OC5.4 | A survey of current clinical care of children and young people with Klinefelter Syndrome in United Kingdom |
| 09:50 | OC5.5 | Pre-hypertension Genes in the Avon Longitudinal Study of Parents and Children (ALSPAC) Predict Higher Systolic Blood Pressure in Children from The Manchester BabyGRO Study |
| 10:00 | OC5.6 | Can clinical, biochemical and genetic parameters help distinguish congenital hypogonadotrophic hypogonadism from self-limited delayed puberty? |
| 10:10 | OC5.7 | Breast milk-induced hypercalcaemia – a retrospective study to describe biochemical and radiological outcomes if no intervention is offered. |
| 10:20 | OC5.8 | Liraglutide improves metabolic profile, glycaemic dysregulation, quality-of-life and eating behaviours in adolescents with severe obesity |
| 10:30 | OC5.9 | Home Waking Salivary Cortisone to screen for Adrenal Insufficiency in Children |
| 09:10-10:40 | | Endocrine Nurses' Business Meeting Chair(s): Peter Laing (Liverpool, UK) & Karen Thompson (Belfast, UK) Lancaster Suite
|
| 09:10-10:40 | | CEW Symposium Chair(s): Senthil Senniappan (Liverpool, UK) & Mars Skae (Manchester, UK) Alex A Suite
|
| 09:10 | CS1.1 | Developing & delivering a national service for CEW |
| 09:40 | CS1.2 | 50 years of obesity: The lived experience |
| 10:10 | CS1.3 | Model of Care for Obesity Management: American Perspective |
| 10:40-11:10 | | Break Trafford Suite
|
| 11:10-12:10 | | Endocrine Symposium 1 Chair(s): Helen Storr (London, UK) & Christina Wei (London, UK) Alex B Suite
|
| 11:10 | ES1.1 | Childhood cancer survival and late effects |
| 11:40 | ES1.2 | Growth hormone safety |
| 11:10-12:10 | | Diabetes Symposium 1 Chair(s): Pooja Sachdev (Nottingham, UK) & Fiona Campbell (Leeds, UK) Alex A Suite
|
| 11:10 | DS1.1 | Preparing for a softer landing at diagnosis – how to manage a child with pre-T1D |
| 11:40 | DS1.2 | Immunotherapy for type 1 diabetes |
| 12:10-12:40 | | Endocrine Oral Communications 2 Chair(s): Charlotte Elder (Sheffield, UK) & Fiona Regan (London, UK) Alex B Suite
|
| 12:10 | OC6.1 | An audit on improving the endocrine management of patients with Duchenne Muscular Dystrophy |
| 12:16 | OC6.2 | Children with hypophosphatasia treated with asfotase alfa: analysis from the UK Patients Cohort |
| 12:22 | OC6.3 | Initial experiences of using the Paediatric Sleep Questionnaire (PSQ) to screen for obstructive sleep apnoea in a tier-3 paediatric weight management clinic |
| 12:28 | OC6.4 | Screening for coeliac disease in paediatric patients diagnosed with Graves’ Disease. |
| 12:34 | OC6.5 | Growth hormone excess in children with pituitary adenomas associated with endocrine syndromes |
| 12:10-12:40 | | Diabetes Oral Communications 1 Chair(s): Wing Yu Tang (Manchester, UK) & Emma Webb (Norwich, UK) Alex A Suite
|
| 12:10 | OC7.1 | Integrating physical activity in structured education programmes to lower hyperglycaemia in children and young people with type 1 diabetes without increasing risk of hypoglycaemia |
| 12:16 | OC7.2 | Retrospective audit of the East of England, Children and Young People Diabetes Network, out of hours consortium provision |
| 12:22 | OC7.3 | How do Accident and Emergency staff perceive new diabetes technologies? A study across two centers |
| 12:28 | OC7.4 | T1D clinic- a novel approach! |
| 12:34 | OC7.5 | Leicester Paediatric Diabetes Unit's ‘Bridge the Gap’ project: Improving access to diabetes technology for children and young people from ethnic minorities and socio-economically deprived families |
| 12:40-14:10 | | Lunch & Exhibition Trafford Suite
|
| 13:15-14:00 | | Poster Tours Derby Suite Foyer (1st Floor)
|
| 13:10-13:55 | | Industry Sponsored Satellite Symposium Alex B Suite
|
| 14:10-14:40 | | James M Tanner Award Chair(s): Tabitha Randell (Nottingham, UK) & Melanie Kershaw (Birmingham, UK) Alex B Suite
|
| 14:10 | A1 | James M Tanner Award |
| 14:40-15:40 | | How Do I? (Endocrine) Chair(s): Indi Banerjee (Manchester, UK) & Christine Burren (Bristol, UK) Alex B Suite
|
| 14:40 | HDI1.1 | How do I manage steroid induced adrenal suppression |
| 15:10 | HDI1.2 | How do I manage metabolic bone disease of prematurity |
| 14:40-15:40 | | How Do I? (Diabetes) Chair(s): Catherine Peters (London, UK) & Toby Candler (Bristol, UK) Alex A Suite
|
| 14:40 | HDI2.1 | How I manage dysglycaemia in cystic fibrosis |
| 15:10 | HD2.2 | How do I manage steroid induced diabetes |
| 15:40-16:10 | | Tea & Coffee Trafford Suite
|
| 16:10-17:10 | | Debate Chair(s): Senthil Senniappan (Liverpool, UK) & Mehul Dattani (London, UK) Alex A Suite
|
| 16:10 | D1.1 | For: Pharmacotherapy as mainstay for obesity management |
| 16:40 | D1.2 | Against: Pharmacotherapy as mainstay for obesity management |
| 16:10-16:40 | | Endocrine Oral Communications 3 Chair(s): Maria Salomon Estebanez (Manchester, UK) & Anitha Kumaran (Southampton, UK) Alex B Suite
|
| 16:10 | OC8.1 | Is there reversal of virilisation after commencing medical replacement therapy for 46XX classical congenital adrenal hyperplasia (CAH)? |
| 16:16 | OC8.2 | Rare variants in the MECP2 gene in girls with central precocious puberty |
| 16:22 | OC8.3 | Dysregulated pathways reveal NOVEL mechanistic insights underlying HMGA2-related growth failure in Silver Russell Syndrome |
| 16:28 | OC8.4 | Association of newborn screening of congenital adrenal hyperplasia with outcomes in the first 90 days of life: a multi-centre I-CAH registry analysis of contemporary practice |
| 16:34 | OC8.5 | Feasibility of integrating an exercise specialist supported by mHealth technology to increase exercise and physical activity in an adolescent Complications from Excess Weight Service: MOTIVATE-CEW |
| 16:40-17:10 | | Personal Practice Session Chair(s): Debbie Matthews (Newcastle, UK) & Ritika Kapoor (London, UK) Alex B Suite
|
| 16:40 | PPS | Management of lipodystrophies |
| 17:30-18:30 | | AGM (BSPED members only) Chair(s): Tabitha Randell (Nottingham, UK) Alex B Suite
|
| 19:30-23:59 | | Conference Dinner Imperial War Museum North, Manchester
|
10 November 2023 |
| 09:00-10:30 | | Diabetes Symposium 2 Chair(s): Martha Ford-Adams (London, UK) & Noina Abid (Belfast, UK) Alex B Suite
|
| 09:00 | DS2.1 | Clinical Research and Real World Updates of Closed loop systems |
| 09:30 | DS2.2 | Pharmacological management of T2DM - adult perspective |
| 10:00 | DS2.3 | Use of CGM in Type 1 diabetes - what's the latest |
| 09:00-10:30 | | Endocrine Symposium 2 (Nurses/Endocrine Professionals session) Chair(s): Peter Laing (Liverpool, UK) & Karen Thompson (Belfast, UK) Alex A Suite
|
| 09:00 | ES2.1 | Integration of nurse-led virtual reviews with growth hormone device-linked patient adherence information: a mixed method study. |
| 09:15 | ES2.2 | Metabolic Bone Service at RMCH – optimising patient care |
| 09:40 | ES2.3 | What is CHI? And the role of the CHI Specialist Practitioners |
| 10:00 | ES2.4 | Establishing the CEW specialist Nursing roles in the North West |
| 10:30-11:15 | | 50 Years of BSPED Chair(s): Peter Clayton (Manchester, UK) Alex B Suite
|
| | Chris Kelnar |
| | Ieuan Hughes |
| | John Wass |
| 11:15-11:45 | | Tea & Coffee Trafford Suite
|
| 11:45-13:15 | | Diabetes Oral Communications 2 Chair(s): Dinesh Giri (Bristol, UK) & Astha Soni (Sheffield, UK) Alex B Suite
|
| 11:45 | OC9.1 | Experience of the digital version of SEREN (Structured Education Reassuring Empowering Nurturing), Diabetes at Diagnosis module- improving paediatric diabetes care |
| 11:55 | OC9.2 | Screening for paediatric type 1 diabetes – A qualitative study of parents and stakeholders |
| 12:05 | OC9.3 | A National Survey on the care and management of Children and Young people with Type 2 Diabetes |
| 12:15 | OC9.4 | Evaluating the impact of a Health Care Assistant for care of children and young people with type 1 diabetes - “Improving the Time to Care” |
| 12:25 | OC9.5 | Impact of using hybrid closed loop system in a tertiary children’s hospital: a single centre experience |
| 12:35 | OC9.6 | How does HbA1c compare with OGTT in identifying patients with Diabetes Mellitus and Pre-Diabetes |
| 12:45 | OC9.7 | Personalised carbohydrate prescriptions using individualised calculations prevent over prescribing carbohydrate to newly diagnosed children and young people with type 1 diabetes. |
| 12:55 | OC9.8 | CFTR modulators and glucose tolerance in children |
| 13:05 | OC9.9 | Quality improvement using PDSA cycles improves performance on NPDA key care processes for Birmingham Children's Hospital |
| 11:45-12:45 | | Nurses/Endocrine Professionals session (Oral Communications 4) Chair(s): Peter Laing (Liverpool, UK) & Karen Thompson (Belfast, UK) Alex A Suite
|
| 11:45 | OC10.1 | The real-world experience of Long acting Growth Hormone in Children with Growth Hormone Deficiency |
| 11:55 | OC10.2 | A Multidisciplinary Approach to the Growth Hormone Shortage |
| 12:05 | OC10.3 | Evaluating the impact of a nurse education refresher session for families who have a child with adrenal insufficiency |
| 12:15 | OC10.4 | The use of Efmody (Modified-release hydrocortisone, MRHC) in Patients with Congenital Adrenal Hyperplasia (CAH): Initial Experience and Patient Feedback |
| 12:25 | OC10.5 | PARENTAL PERSPECTIVE ON GENITOPLASTY FOR GIRLS WITH VIRILISING CONGENITAL ADRENAL HYPERPLASIA |
| 12:35 | OC10.6 | An Appraisal on The Quality and Readability of Growth Hormone Therapy Patient Information Developed by Paediatric Endocrine Societies |
| 12:45-13:00 | | Presentations from Previous Award Winners Chair(s): Senthil Senniappan (Liverpool, UK) & Sabah Alvi (Leeds, UK) Alex A Suite
|
| 12:45 | | I-HH – development of a electronic registry for hypogonadotropic hypogonadism, the 4th module in the I-DSD registry |
| 13:15-14:30 | | Lunch & Exhibition Trafford Suite
|
| 13:15-14:00 | | Poster Tours Derby Suite (1st Floor)
|
| 13:30-14:00 | | Industry Sponsored Expert Insights Session Alex B Suite
|
| 14:30-16:00 | | Diabetes Symposium 3 Chair(s): Deborah Kendall (Preston, UK) & James Law (Nottingham, UK) Alex B Suite
|
| 14:30 | DS3.1 | Hospital care at home and virtual wards for diabetes |
| 15:00 | DS3.2 | Managing lipid abnormalities in T1DM |
| 15:30 | DS3.3 | Foot problems in diabetes mellitus: prevention and management |
| 14:30-16:00 | | Endocrine Symposium 3 Chair(s): Guftar Shaikh (Glasgow, UK) & Raja Padidela (Manchester, UK) Alex A Suite
|
| 14:30 | ES3.1 | Rasopathies in short stature conditions |
| 15:00 | ES3.2 | Treatment of achondroplasia - an update |
| 15:30 | ES3.3 | Managing rare forms of CAH |
| 16:00-16:15 | | BSPED 2023 Awards Session Chair(s): Senthil Senniappan (Liverpool, UK) & Nadia Amin (Leeds, UK) Alex B Suite
|
| 16:15-16:30 | | Close of Meeting Chair(s): Senthil Senniappan (Liverpool, UK) & Mars Skae (Manchester, UK) Alex B Suite
|